glp-1-based therapies Optimizing GLP-1 for obesity and diabetes management Timeline of GLP-1 discovery and

A short-term (90 min) stimulation with GLP-1 did not cause changes in glucose and lipid oxidation in rodent islets 15 , although, the same study reported a significant increase in glucose utilization, which perhaps has not been given sufficient attention

A common question now emerging is whether GLP-1 medications cause nutrient deficiencies

Understanding the complex relationship between weight loss medications and sexual health helps patients and clinicians make informed treatment decisions

Because of this, it is a potent tool for managing type 2 diabetes, especially in people who have trouble with insulin resistance

Your weight-loss journey starts here